| 000 | 01282 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511231220.0 | ||
| 264 | 0 | _c19901213 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0091-3952 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJori, M C | |
| 245 | 0 | 0 |
_aClinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease. _h[electronic resource] |
| 260 |
_bAdvances in neurology _c1990 |
||
| 300 |
_a539-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntiparkinson Agents |
| 650 | 0 | 4 | _aCabergoline |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aErgolines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeurologic Examination |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 700 | 1 | _aFranceschi, M | |
| 700 | 1 | _aGiusti, M C | |
| 700 | 1 | _aCanal, N | |
| 700 | 1 | _aPiolti, R | |
| 700 | 1 | _aFrattola, L | |
| 700 | 1 | _aBassi, S | |
| 700 | 1 | _aCalloni, E | |
| 700 | 1 | _aMamoli, A | |
| 700 | 1 | _aCamerlingo, M | |
| 773 | 0 |
_tAdvances in neurology _gvol. 53 _gp. 539-43 |
|
| 999 |
_c2245586 _d2245586 |
||